Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis
Abstract Background In order to appraise the risk-benefit balance of the three available dual orexin receptor antagonists (DORAs; daridorexant, lemborexant, and suvorexant) for the management of adults with insomnia, we conducted a systematic review and random-effects model network meta-analysis. Me...
Saved in:
Main Authors: | Taro Kishi, Toshikazu Ikuta, Leslie Citrome, Kenji Sakuma, Masakazu Hatano, Shun Hamanaka, Yasufumi Nishii, Nakao Iwata |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-06-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-025-03439-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
by: Taro Kishi, et al.
Published: (2015-01-01) -
Suvorexant: a promising, novel treatment for insomnia
by: Lee-Iannotti J, et al.
Published: (2016-02-01) -
Gut Microbiome Composition Changes During Insomnia Treatment with Lemborexant
by: Miyata S, et al.
Published: (2025-07-01) -
Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis.
by: Shinji Matsunaga, et al.
Published: (2015-01-01) -
Pharmacotherapy of insomnia in childhood
by: Z. G. Tadtaeva, et al.
Published: (2022-07-01)